Antifungal susceptibility and virulence factors of clinically isolated dermatophytes in Tehran, Iran
,
Abstract
Background and Objectives: Dermatophytes possess a wide array of virulence factors and various antifungal susceptibility patterns which influence their pathogenesis in humans and animals. The aim of this study was to evaluate antifungal suscep- tibility and keratinase and proteinase activity of 49 dermatophyte strains from the genera Microsporum, Trichophyton and Epidermophyton which were isolated from human cases of dermatophytosis.
Materials and Methods: Forty-nine dermatophyte strains isolated from clinical samples were cultured on general and spe- cific culture media. Keratinase and proteinase activity was screened on solid mineral media and confirmed in liquid cultures. Drug susceptibility toward azoles (fluconazole, ketoconazole and itraconazole), griseofulvin and terbinafine was evaluated using disk diffusion method on Mueller-Hinton agar and minimum inhibitory concentrations (MICs) were determined using microbroth dilution assay according to the Clinical and Laboratory Standards Institute (CLSI) guidelines.
Results: Our results indicated that clinically isolated dermatophytes from 7 major species produced keratinase and protein- ase at different extents. The mean keratinase and proteinase activity was reported as 6.69 ± 0.31 (U/ml) and 2.10 ± 0.22 (U/ ml) respectively. Disk diffusion and microbroth dilution (MIC) results of antifungal susceptibility testing showed that ke- toconazole was the most effective drug against Epidermophyton floccosum and Trichophyton mentagrophytes, itraconazole against T. rubrum and E. floccosum, and griseofulvin and terbinafine against Trichophyton verrucosum. Our results showed that all dermatophyte isolates were resistant to fluconazole. Overall, ketoconazole and itraconazole were the most effective drugs for all dermatophyte species tested.
Conclusion: Our results showed that antifungal susceptibility testing is an urgent need to select drugs of choice for treatment of different types of dermatophytosis and further indicated the importance of keratinase and proteinase in pathogenesis of dermatophyte species.
Ameen M. Epidemiology of superficial fungal infec- tions. J Clin Dermatol 2010;28:197-201.
Havlickova B, Czaika VA. Epidemiological trends in skin mycoses worldwide. Mycoses 2008; 51:2-15.
Achterman RR, White TC. Dermatophyte virulence fac- tors: Identifying and analyzing genes that may contrib- ute to chronic or acute skin infections. Int J Microbiol 2012; 358305.
Jankowska- Konsur A, Dylag M, Hryncewicz- Gwozdz A, Plomer-Niezgoda E, Szepietowski CJ. A 5-year survey of dermatomycoses in southwest Poland, years 2003-2007. Mycoses 2011; 54:162-167.
Oyeka CA, Eze II. Fungal skin infections among prison inmates in Abakaliki, Nigeria. Mycoses 2007;51:50-54.
Marques SA, Robles AM, Tortorano AM, Tuculet MA, Negron R, Mendes RP. Mycoses associated with AIDS in the third world. Med Mycol 2000;38:269-279.
Ghahfarokhi MS, Goodarzi M, Abyaneh MR, Al-Ti- raihi T, Seyedipour G. Morphological evidences for onion-induced growth inhibition of Trichophyton ru- brum and Trichophyton mentagrophytes. Fitoterapia 2004;75:645-655.
Shams-Ghahfarokhi M, Shokoohamiri MR, Amirrajab N, Moghadasi B, Ghajari A, Zeini F, et al. In vitro an- tifungal activities of Allium cepa, Allium sativum and ketoconazole against some pathogenic yeasts and der- matophytes. Fitoterapia 2006;77:321-323.
White TC, Oliver BG, Graser, Y, Henn MR. Generat- ing and testing molecular hypotheses in the dermato- phytes. Eukaryot Cell 2008;7:1238–1245.
Macura AB. In vitro susceptibility of dermatophytes to antifungal drugs: a comparison of two methods. Int J Dermatol 1993;32:533-536.
Muhsin T.M, Hadi R.B. Incidence of keratinolytic and dermatophytic fungi in sewage sludge in Basrah, Iraq. J Basrah Res (Sciences) 2011;37:3-15.
Cabans FJ. Dermatophytes in domestic animals. In: Kushwaha RKS, Guarro J (Eds.). Biology of Der- matophytes and other Keratinophilic Fungi. Revista Iberoam Micol 2000; pp. 104-108.
Sevtap A. Current status of antifungal susceptibility testing methods. Med Mycol 2007;45:569-587.
Weitzman I, Summerbell RC. The dermatophytes. Clin Microbiol Rev 1995;8:240–259.
Coelho LM, Aquino-Ferreira R, Maffei CM, Marti- nez-Rossi NM. In vitro antifungal drug susceptibilities of dermatophytes microconidia and arthroconidia. J Antimicrob Chemother 2008;62:758-761.
Pakshir K, Bahaedinie L, Rezaei Z, Sodaifi M, Zo- morodian K. In vitro activity of six antifungal drugs against clinically important dermatophytes. Jundisha- pur J Microbiol 2009;2:158-163.
Nyilasi I, Kocsube S, Krizsa´n K, Galgo L, Papp T, Pesti M, Nagy K. Susceptibility of clinically importantder-matophytes against statins and different statin-antifun- gal combinations. Med Mycol 2014;52:140-148.
Jessup CJ, Warner J, Isham N, Haasan I, Ghannoum MA. Antifungal susceptibility testing of dermato- phytes: establishing a medium for inducing conidial growth and evaluation of susceptibility of clinical iso- lates. J Clin Microbiol 2000;38:341–344.
Nweze EI, Mukherjee PK, Ghannoum MA. Agar-based disk diffusion assay for susceptibility testing of derma- tophytes. J Clin Microbiol 2010;48:3750–3752.
Nweze EI, Ogbonna C, Okafor JI. In vitro Suscepti- bility testing of dermatophytes isolated from pediatric cases in Nigeria against five antifungals. Rev Inst Med Trop S Paulo 2007; 49:293-295.
Adimi P, Hashemi SJ, Mahmoudi M, Mirhendi H, Shid- far M.R, Emmami M, et al. In-vitro activity of 10 an- tifungal agents against 320 dermatophyte strains using microdilution method in Tehran. Iranian J Pharmaceut Res 2013;12:537-545.
Wawarzkiewicz K, Wolski T, Labarzewski J. Screen- ing the keratinolytic activity of derrmatophyte in vitro. Mycopathologia 1991;114:1-8.
Apodaca G, Mckerrow JH. Purification and character- ization of a 27,000-M exteracellular proteinase from Trichophyton rubrum. Infect Immun 1989;57:3072-3080.
John HR, Barbara D. Reference method for broth di- lution antifungal susceptibility testing of filamentous fungi. Wayne. A clinical and laboratory standards In- stitute 2008; Vol 28: No. 16.
Araujo CR, Miranda KC, Orionald A. In vitro suscepti- bility testing of dermatophyes isolated in Goiania Bra- zil, against five antifungal agents by broth microdilu- tion method. Rev Inst Med Trop S Paulo 2009;51:9-12.
Coelho LM, Aquino-Ferreira R, Maffei CM, Marti- nez-Rossi NM. In vitro antifungal drug susceptibilities of dermatophytes microconidia and arthroconidia. J Antimicrob Chemother 2008;62:758–761.
Sharma A, Chandra S, Sharma M. Difference in kera- tinase activity of dermatophytes at different environ- mental conditions is an attribute of adaptation to para- sitism. Mycoses 2012; 55:410-415.
Muhsin TM, Salih TH. Exocellular enzyme activity of dermatophytes and other fungi isolated from ruminants in Southern Iraq. Mycopathologia 2001; 150:49-52.
Apodaca G, McKerrow JH. Regulation of Tricho- phyton rubrum proteolytic activity. Infect Immun 1989;57:3081-3090.
Shams-Ghahfarokhi M, Razafsha M, Allameh A, Razzaghi-Abyaneh M. Inhibitory effects of aqueous onion and garlic extracts on growth and keratinase ac- tivity in Trichophyton mentagrophytes. Iran Biomed J2003;7:113-118.
Sadeghi G, Abouei M, Alirezaee M, Tolouei R,Shams-Ghahfarokhi M, Mostafavi E, et al. A 4-year survey of dermatomycoses in Tehran from 2006 to 2009. J Med Mycol 2011;21:260-265.
Goh CL, Tay YK, Ali KB, Koh MT, Seow CS. In vitro evaluation of griseofulvin, ketoconazole, and itracon- azole against various dermatophytes in Singapore. Int J Dermatol 1994;33:733-737.
Gupta AK, Kohli Y. In vitro susceptibility testing of ciclopirox, terbinafine, ketoconazole and itraconazole against dermatophytes and non-dermatophytes, and in vitro evaluation of combination antifungal activity. Br J Dermatol 2003;149:296-305.
Ghannoum M, Skaggs B, Sheehan D. Voriconazle sus- ceptibilities of dermatophyte isolates obtained from a worldwide tinea capitis clinical trial. J Clin Microbiol 2006;44:2579–2580.
Agarwal RK, Gupta S, Mittal G, Khan F, Roy S, Agar- wal A. Antifungal susceptibility testing of dermato- phytes by agar-based disk diffusion method. Int J Curr Microbiol Appl Sci 2015;4:430-436.
Barros ME, Santos DA, Hamda JS. Evaluation of susceptibility of Trichophyton ment agrophytes and Trichophyton rubrum clinical isolates to antifungal drugs using a modified CLSI microdilution method (M38-A). J Med Microbiol 2007;56:514–518.
Fernandez-Torres B, Cabanes FJ, Carrillo-Mun˜oz AJ, Esteban A, Inza I, Abarca L, et al. Collaborative evaluation of optimal antifungal susceptibility test- ing conditions for dermatophytes. J Clin Microbiol 2002;40:3999–4003.
| Files | ||
| Issue | Vol 8 No 1 (2016) | |
| Section | Articles | |
| Keywords | ||
| Dermatophytes Antifungal susceptibility testing Keratinase activity Proteinase activity Virulence factors | ||
| Rights and permissions | |
|
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
